Results 61 to 70 of about 3,148,135 (237)

Fixed drug eruption related to sunitinib: a case report [PDF]

, 2018
Sunitinib is an oral multi-targeted tyrosine kinase inhibitor. It has been approved for the treatment of gastro-intestinal stromal tumor and advanced renal cell carcinoma.
Bhatia, Anuradha, Jha, Niharika, Kanish, Bimal, Bhatia, Anuradha ; Jha, Niharika ; Kanish, Bimal, Niharika Jha, Bimal Kanish, Anuradha Bhatia   +6 more
core   +1 more source

Pembrolizumab‐Induced Subacute Cutaneous Lupus Erythematosus: A Case Report

JEADV Clinical Practice, EarlyView.
ABSTRACT Subacute cutaneous lupus erythematosus (SCLE) is an increasingly recognized cutaneous immune‐related adverse event of immune checkpoint inhibitors. We report an 83‐year‐old woman who developed pruritic annular and polycyclic plaques 10 weeks after starting pembrolizumab for oropharyngeal squamous cell carcinoma.
Sebastiano Posenato, Alba Guglielmo, Lucia Mantovani, Aikaterini Kalpaktsoglou, Simone Cavaliere, Alessandro Borghi   +5 more
wiley   +1 more source

Fixed Eruptions: Drug, food, and what more?

Clinical Dermatology Review
Fixed drug eruption (FDE) is a common entity encountered in our day-to-day clinical practice. It is a T-cell-dependent pathway with induction of interferon-gamma-producing CD8+ T-cells in the dermis and epidermis.
Prabhakar Mallikarjuna Sangolli, Neethu Mary George   +1 more
doaj   +1 more source

Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense, Nicole Bavaro, Aashna Farishta, Jiaqi Chen, Raj Chovatiya   +4 more
wiley   +1 more source

A Rare Case Report of Localized Bullous Fixed Drug Eruption Due to Tamsulosin

JK Science, 2023
Fixed drug eruption is a cutaneous adverse reaction to a specific drug. Tamsulosin is an alpha-1 adrenergic receptor blocker used to treat benign prostatic hyperplasia in men.
Sheba Mariam Jacob, Thillaikarasi A, Narasimhalu C.R.V, Vimal Chander R   +3 more
doaj  

Multifocal fixed drug eruption with COX-2 inhibitor-celecoxib

Indian Journal of Dermatology, 2013
Cyclooxygenase-2 (COX-2) inhibitors are rapidly becoming the first choice nonsteroidal anti-inflammatory drugs (NSAIDs) for various rheumatological and other painful conditions.
Shikha Chugh, Rashmi Sarkar, Vijay K Garg, Avninder Singh, Chitralekha Keisham   +4 more
doaj   +1 more source

Bio‐Derived Carbon Nanoparticles: A Green Amendment for Alleviating Heavy Metals in Soil–Plant Systems

Land Degradation &Development, EarlyView.
ABSTRACT Heavy metal (HM) contamination of soil–plant systems poses persistent ecological and health risks, driving interest in nanoparticle‐based remediation. Although conventional chemically synthesized nanoparticles (CSNPs) are effective, their energy‐intensive production and residual toxicity limit sustainable deployment.
Babar Hussain, Muhammad Nauman, Zahid Hussain, Palanisamy Vasudhevan, Abdulaziz G. Alghamdi, Shiyong Sun, Shengyan Pu   +6 more
wiley   +1 more source

Fixed Drug Eruption in an Epileptic Patient Previously Receiving Treatment With Phenytoin for Seven Years

Journal of Investigative Medicine High Impact Case Reports, 2013
A 52-year-old African American female presented with severe left thigh pain of unknown etiology. She had a past medical history of generalized seizure disorder treated with phenytoin for 7 years without incident.
Keaton S. Smetana, Katie J. Suda PharmD, MS, Leslie A. Hamilton PharmD   +2 more
doaj   +1 more source

Fixed Drug Eruption due to Achiote Dye

Case Reports in Dermatology, 2016
Fixed drug eruption (FDE) is a localized type IV sensitivity reaction to a systemically introduced allergen. It usually occurs as a result of new medication, making identification and avoidance of the trigger medication straightforward; however, in a ...
Ian Tattersall, Bobby Y. Reddy
doaj   +1 more source

Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report [PDF]

, 2018
Cutaneous adverse reactions to medications are extremely common and display characteristic clinical morphology. A fixed drug eruption is a cutaneous adverse drug reaction due to type IV or delayed cell-mediated hypersensitivity.
Ngwasiri, Calypse Asangbe, Ngwasiri, CA, Aminde, LN, Abanda, Martin Hongieh, Martin Hongieh Abanda, Leopold Ndemnge Aminde, Calypse Asangbe Ngwasiri, Aminde, Leopold Ndemnge, Abanda, MH   +8 more
core   +1 more source